Загрузка...
Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
Hydroxycarbamide is used in the treatment of essential thrombocytosis and other myeloproliferative disorders. We report the case of a 63-year-old woman with essential thrombocytosis who had melanonychia after the long-term use of the hydroxycarbamide with a dose of 1000 mg/day. Two years after the i...
Сохранить в:
| Опубликовано в: : | Case Rep Hematol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4537733/ https://ncbi.nlm.nih.gov/pubmed/26301108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/653178 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|